Rasuric 1.5mg Injection
Marketer
Aureate Healthcare Pvt Ltd
Salt Composition
Rasburicase (1.5mg)
Overview Rasuric 1.5mg Injection
Uricolytic injection, Rasuric 1.5mg, treats chemotherapy-induced hyperuricemia. It reduces serum uric acid, mitigating kidney damage in oncology patients. Administered intravenously by a healthcare professional via slow injection, dosage and frequency are determined individually by your physician, adapting to treatment needs. Strictly adhere to prescribed instructions; improper use or overdose risks severe adverse events. Therapeutic effects may take weeks or months; discontinue only under medical supervision. Common side effects include nausea, headache, vomiting, and skin rash. Seek immediate medical attention for serious reactions like dyspnea, chest pain, facial/throat swelling, pruritus, or vertigo. Regular blood uric acid monitoring may be conducted. Adequate hydration is recommended. Inform your doctor about all medications and pre-existing conditions to ensure safe and effective use, as drug interactions are possible.
Uses of Rasuric 1.5mg Injection
Managing hyperuricemia secondary to cytotoxic therapy
Major Benefits of Rasuric 1.5mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Rasuric 1.5mg Injection:
- Nausea
- Headache
- Vomiting
- Rash
- Hives
- Fever
- Diarrhea
How to use Rasuric 1.5mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strictly prohibited.
How Rasuric 1.5mg Injection works:
Rasuric 1.5mg Injection lowers uric acid levels by interacting with an enzyme to convert uric acid into the inert compound allantoin.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Rasuric 1.5mg Injection may pose safety risks; physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Rasuric 1.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescription. Physician consultation is recommended.
Breast feedingSAFE IF PRESCRIBED
Administering Rasuric 1.5mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Rasuric 1.5mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
In patients with kidney disease, Rasuric 1.5mg Injection is likely safe. Available evidence indicates dose modification may not be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Rasuric 1.5mg Injection appears safe for use in individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is advised.
What if you forget to take Rasuric 1.5mg Injection :
NA
Facts to Know About Rasuric 1.5mg Injection
| Label | Value |
|---|---|
| Type of Compound | Engineered Xanthine Oxidase |
| Potential for Dependence | None. |
| Type of Medication | Hematological |
| Mechanism of Action | Chemotherapy with uric acid-lowering medication |
3,018 People bought this recently